Medicines Australia Board Director Prof John Skerritt recognised in King’s Honours list

11 June 2024: Medicines Australia congratulates independent Board Director, Prof John Skerritt, on his appointment as a Member of the Order of Australia (AM) in the General Division in the 2024 King’s Birthday Honours list.

Prof Skerritt was recognised for ‘significant service to public health administration and governance, and to scientific research’ which includes joint roles as head of the TGA and Deputy Secretary from 2012 to 2023.

In addition, Prof Skerritt was a member of the Australia-NZ Clinical Trial Registry Advisory Board from 2012-2021. He is a Professor of Medicine at Melbourne University, and an Adjunct Professor at Sydney University, and joined the Board of Medicines Australia as an independent Director in 2023.

Medicines Australia Chair, Dr Anna Lavelle, commended Prof Skerritt on his achievements and said all Australians have benefited from his contribution to the therapeutic regulatory environment, clinical trials system and broader health system.

“Professor Skerritt has made a significant contribution to Australia’s healthcare system over the last 15 years, through his leadership and deep understanding of regulation and government processes. This has come at a pivotal time when innovation in medical technologies has advanced at a faster pace than ever before, requiring a cautious but willing approach to embrace change.”

“Medicines Australia is very fortunate to be able to draw on John’s expertise as an independent Board Director and we warmly congratulate him on this tremendous recognition of his service.”

___________________________________________________________________________

Media enquiries to Kate McKeown, Senior Manager Communications and Media – kate.mckeown@medicinesaustralia.com.au or 0408 775 288.